Rubin Lab

RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

SARS Vaccine and IBD Tweetorial Summary from December 1

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

“Monitor Histologically Normalized UC for Relapse” on MedPage Today

"These patients require ongoing monitoring and follow-up," the study's first author, Amanda M. Israel, MD, also of the University of Chicago Medicine, told MedPage Today. Our graduating Advanced IBD Fellow, Amanda Israel, was published her findings on the “Follow-Up...

Dr. Rubin Taps in on “IBD Community Throwing Elbows Over Value of TDM” in Gastroenterology and Endoscopy News

Dr. Mark Silverberg, Dr. David T Rubin, Dr. Laura Targownik, and Dr. Charabaty excitingly discuss why IBD specialists are divided on the topic of therapeutic drug monitoring (TDM). “If the drug is going to work but isn’t present in the body, it doesn’t do its job,”...

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Dr. David T. Rubin Guest-Hosts IBD Drive Time

Take a listen to Dr. Rubin discuss the impact of inflammatory bowel disease on sexual function with University of Chicago's GI psychologist, Dr. Alyse Bedell, and pelvic floor physical therapist, Sarah Macaraeg.

Pursuing a Gut Feeling: Exploring Immune Cell Trafficking Inhibitors to Treat IBD

Click here to watch Dr. Rubin and Dr. Long review the role of cell trafficking in IBD pathogenesis and how therapies that modulate immune cell trafficking compare with other agents that target the inflammatory response in IBD.

G&E News Expert Picks by Dr. Rubin: Best of ECCO 2019

'In this installment of “Expert Picks,” David Rubin, MD, the Joseph B. Kirsner Professor of Medicine; the chief of the Section of Gastroenterology, Hepatology, and Nutrition; and a co-director of the Digestive Diseases Center at the University of Chicago Medicine and...

Should You Scale Back on Your UC Treatment?

A provocative new paper proposes that less could be more for some people when it comes to drug therapy for IBD. https://www.healthcentral.com/news/ulcerative-colitis/should-you-scale-back-on-your-uc-treatment

Dr. David T. Rubin on Transabdominal Ultrasound for IBD: Lessons from STARDUST Substudy on Ustekinumab

Intestinal ultrasound has become a useful tool in assessing disease progression and pathophysiology of inflammatory bowel disease (IBD). It’s an approach to visualizing the intestines using a transabdominal ultrasound probe to provide real-time information. But could...

How UC Affects Your Sex Life

Many people with Ulcerative Colitis wonder whether it’s possible to have a satisfying sex life. Dr. David Rubin discusses how to address the situation with your physician and partner. Read more here.

Dr. David T. Rubin Guest-Hosts IBD Drive Time, Again!

In the second of a four-part series guest-hosting the Gastroenterology Learning Network's IBD Drive Time, Dr. Rubin discusses the impact of the obstacles of the prior authorization process on patients and providers. Listen here, as he is joined by David Choi,...